These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 891494)

  • 1. Phenytoin encephalopathy as probable idiosyncratic reaction: case report.
    Ambrosetto G; Tassinari CA; Baruzzi A; Lugaresi E
    Epilepsia; 1977 Sep; 18(3):405-8. PubMed ID: 891494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenytoin-induced encephalopathy in a child.
    Mehndiratta S
    Indian J Pharmacol; 2016; 48(4):460-461. PubMed ID: 27756964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paroxysmal dyskinesia during treatment with diphenylhydantoin].
    Dravet C; Dalla Bernardina B; Mesdjian E; Galland MC; Roger J
    Rev Neurol (Paris); 1980; 136(1):1-14. PubMed ID: 7394437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin metabolism in pregnancy.
    Kochenour NK; Emery MG; Sawchuk RJ
    Obstet Gynecol; 1980 Nov; 56(5):577-82. PubMed ID: 7432728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of plasma exchange on phenytoin plasma concentration.
    Silberstein LE; Shaw LM
    Ther Drug Monit; 1986; 8(2):172-6. PubMed ID: 3726930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calculating how long phenytoin intoxication lasts].
    Sánchez-Romero A; Durán-Ferreras E; Espigares-Jiménez M; Durán-Quintana JA
    Rev Neurol; 2003 Sep 16-30; 37(6):539-40. PubMed ID: 14533073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case report of phenytoin encephalopathy. Correlation between serum levels, seizure increase and E.E.G. spike and wave activity.
    Zwarts MJ; Sie O
    Clin Neurol Neurosurg; 1985; 87(3):205-8. PubMed ID: 4053475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic diphenyl hydantoin encephalopathy in mentally retarded children and adolescent with severe epilepsy.
    Meistrup-Larsen KI; Hermann S; Permin H
    Acta Neurol Scand; 1979 Jul; 60(1):50-5. PubMed ID: 495042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of intravenous phenytoin in treatment of partial status epilepticus (author's transl)].
    Chauplannaz G; Mauguière F; Courjon J; Ferry S
    Nouv Presse Med; 1981 Mar; 10(13):1043-6. PubMed ID: 6784103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loading and conventional dose therapy with phenytoin in children: kinetic profile of parent drug and main metabolite in plasma.
    Wilson JT; Höjer B; Rane A
    Clin Pharmacol Ther; 1976 Jul; 20(1):48-58. PubMed ID: 132330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic observations of phenytoin disposition in the newborn and young infant.
    Loughnan PM; Greenwald A; Purton WW; Aranda JV; Watters G; Neims AH
    Arch Dis Child; 1977 Apr; 52(4):302-9. PubMed ID: 871217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma concentrations of 5-(4-hydroxyphenyl)-5-phenylhydantoin in phenytoin-treated patients.
    Hoppel C; Garle M; Rane A; Sjöqvist F
    Clin Pharmacol Ther; 1977 Mar; 21(3):294-300. PubMed ID: 837648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excretion of phenytoin into semen of rabbits and man. Comparison with plasma levels.
    Swanson BN; Leger RM; Gordon WP; Lynn RK; Gerber N
    Drug Metab Dispos; 1978; 6(1):70-4. PubMed ID: 23276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein binding and CSF penetration of phenytoin following acute oral dosing in man.
    Brodie MJ; Muir SE; Agnew E; MacPhee GJ; Volo G; Teasdale E; MacPherson P
    Br J Clin Pharmacol; 1985 Feb; 19(2):161-8. PubMed ID: 3986076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum diphenylhydantoin in epileptic patients (preliminary report)].
    Radzikowska B; Zadrozyńska E; Pakszys W
    Neurol Neurochir Pol; 1977; 11(5):551-4. PubMed ID: 593505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is free fraction measurement of phenytoin always necessary in pediatric epileptic patients?
    Johno I; Kuzuya T; Suzuki K; Hasegawa M; Nakamura T; Kitazawa S; Aso K; Watanabe K
    Ther Drug Monit; 1988; 10(1):39-44. PubMed ID: 3376180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels and renal excretion of phenytoin and its metabolites in patients with renal failure.
    Borgå O; Hoppel C; Odar-Cederlöf I; Garle M
    Clin Pharmacol Ther; 1979 Sep; 26(3):306-14. PubMed ID: 466924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenytoin toxic encephalopathy.
    Lewin S; Rao SD; Chandrasekhara MK; Vengamma B
    Indian Pediatr; 1993 Jan; 30(1):79-80. PubMed ID: 8406715
    [No Abstract]   [Full Text] [Related]  

  • 19. Relationship between serum and brain concentrations of phenytoin in the dog.
    Sanders JE; Yeary RA; Powers JD; de Wet P
    Am J Vet Res; 1979 Apr; 40(4):473-6. PubMed ID: 517820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative controlled study between carbamazepine and diphenylhydantoin in psychomotor epilepsy.
    Simonsen N; Olsen PZ; Kühl V; Lund M; Wendelboe J
    Epilepsia; 1976 Jun; 17(2):169-76. PubMed ID: 780103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.